| 000 | 01517 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513235309.0 | ||
| 264 | 0 | _c20010726 | |
| 008 | 200107s 0 0 eng d | ||
| 022 | _a0143-4004 | ||
| 024 | 7 |
_a10.1053/plac.2001.0636 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPostovit, L M | |
| 245 | 0 | 0 |
_aDoes nitric oxide play a role in the aetiology of pre-eclampsia? _h[electronic resource] |
| 260 |
_bPlacenta _cApr 2001 |
||
| 300 |
_aS51-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCell Adhesion _xdrug effects |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Movement _xdrug effects |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
| 650 | 0 | 4 |
_aNitric Oxide Synthase _xbiosynthesis |
| 650 | 0 | 4 | _aNitric Oxide Synthase Type II |
| 650 | 0 | 4 |
_aNitroglycerin _xpharmacology |
| 650 | 0 | 4 |
_aNitroprusside _xpharmacology |
| 650 | 0 | 4 |
_aPre-Eclampsia _xetiology |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xantagonists & inhibitors |
| 650 | 0 | 4 | _aReceptors, Urokinase Plasminogen Activator |
| 650 | 0 | 4 |
_aTrophoblasts _xcytology |
| 700 | 1 | _aAdams, M A | |
| 700 | 1 | _aGraham, C H | |
| 773 | 0 |
_tPlacenta _gvol. 22 Suppl A _gp. S51-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/plac.2001.0636 _zAvailable from publisher's website |
| 999 |
_c11247102 _d11247102 |
||